The CMS said it will use existing evaluation and management codes to reimburse eligible health care providers for counseling patients about the importance of self-isolation after they are tested for COVID-19. The agency also released new payment codes effective Aug. 1 for remdesivir and convalescent plasma that will allow real-time tracking of their use and effectiveness.
CMS to reimburse for COVID-19 isolation counseling
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.